Systemic cytokine response in patients with community-acquired pneumonia

European Respiratory Journal

Volumn 37, Issue 6, 2011, Pages 1431-1438

  Endeman, H ^a,b   Meijvis, S C A ^a   Rijkers, G T ^a   Van Velzen Blad, H ^a   Van Moorsel, C H M ^a   Grutters, J C ^a   Biesma, D H ^c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chemokines; Corticoids; Cytokines; Pneumonia; Polymorphism

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DNA; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENOTYPE; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS PNEUMONIAE; VIRUS IDENTIFICATION;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79958017458     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00074410     Document Type: Article

References (53)

1. Garau J, Baquero F, Perez-Trallero E, et al. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect 2008; 14: 322-329. (Pubitemid 351356522)
2. Kolling UK, Hansen F, Braun J, et al. Leucocyte response and antiinflammatory cytokines in community acquired pneumonia. Thorax 2001; 56: 121-125. (Pubitemid 32142676)
3. Tuomanen E, Rich R, Zak O. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis 1987; 135: 869-874. (Pubitemid 17055516)
4. van der Poll T, de Waal MR, Coyle SM, et al. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis 1997; 175: 118-122. (Pubitemid 27020832)
5. Ziegler-Heitbrock HW, Passlick B, Kafferlein E, et al. Protection against lethal pneumococcal septicemia in pigs is associated with decreased levels of interleukin-6 in blood. Infect Immun 1992; 60: 1692-1694.
6. Takashima K, Tateda K, Matsumoto T, et al. Role of tumor necrosis factor a in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 1997; 65: 257-260. (Pubitemid 27008930)
7. Rijneveld AW, Florquin S, Branger J, et al. TNF-α compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol 2001; 167: 5240-5246. (Pubitemid 33009761)
8. Kerr AR, Irvine JJ, Search JJ, et al. Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect Immun 2002; 70: 1547-1557. (Pubitemid 34163434)
9. Preston JA, Beagley KW, Gibson PG, et al. Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia. Eur Respir J 2004; 23: 224-231. (Pubitemid 38195507)
10. Khan AQ, Shen Y, Wu ZQ, et al. Endogenous pro- and antiinflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun 2002; 70: 749-761. (Pubitemid 34083837)
11. Zeng X, Moore TA, Newstead MW, et al. Intrapulmonary expression of macrophage inflammatory protein 1a (CCL3) induces neutrophil and NK cell accumulation and stimulates innate immunity in murine bacterial pneumonia. Infect Immun 2003; 71: 1306-1315. (Pubitemid 36254315)
12. Amano H, Morimoto K, Senba M, et al. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J Immunol 2004; 172: 398-409. (Pubitemid 38020494)
13. Puren AJ, Feldman C, Savage N, et al. Patterns of cytokine expression in community-acquired pneumonia. Chest 1995; 107: 1342-1349.
14. Majetschak M, Flohe S, Obertacke U, et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999; 230: 207-214. (Pubitemid 30191887)
15. Dehoux MS, Boutten A, Ostinelli J, et al. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994; 150: 710-716. (Pubitemid 24291499)
16. Tateda K, Moore TA, Deng JC, et al. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J Immunol 2001; 166: 3355-3361. (Pubitemid 33117336)
17. Kolsuz M, Erginel S, Alatas O, et al. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia. Respiration 2003; 70: 615-622. (Pubitemid 38142314)
18. Monton C, Torres A, El-Ebiary M, et al. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999; 27: 1745-1753. (Pubitemid 29455099)
19. Fernandez-Serrano S, Dorca J, Coromines M, et al. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 2003; 10: 813-820. (Pubitemid 37129493)
20. Glynn P, Coakley R, Kilgallen I, et al. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999; 54: 51-55. (Pubitemid 29103752)
21. Antunes G, Evans SA, Lordan JL, et al. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002; 20: 990-995. (Pubitemid 35175139)
22. von Dossow V, Rotard K, Redlich U, et al. Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care 2005; 9: R662-R669.
23. Arnalich F, Lopez-Maderuelo D, Codoceo R, et al. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 2002; 127: 331-336. (Pubitemid 34233940)
24. Schluter B, Raufhake C, Erren M, et al. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 2002; 30: 32-37. (Pubitemid 34112173)
25. Gallagher PM, Lowe G, Fitzgerald T, et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003; 58: 154-156. (Pubitemid 36183005)
26. Schaaf BM, Boehmke F, Esnaashari H, et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003; 168: 476-480. (Pubitemid 37046878)
27. Sutherland AM, Walley KR, Manocha S, et al. The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Intern Med 2005; 165: 75-82. (Pubitemid 40096085)
28. Schaaf B, Rupp J, Muller-Steinhardt M, et al. The interleukin-6 -174 promoter polymorphism is associated with extrapulmonary bacterial dissemination in Streptococcus pneumoniae infection. Cytokine 2005; 31: 324-328. (Pubitemid 41097369)
29. Stuber F, Petersen M, Bokelmann F, et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384. (Pubitemid 26097828)
30. Fine MJ, Singer DE, Hanusa BH, et al. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med 1993; 94: 153-159. (Pubitemid 23046440)
31. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250. (Pubitemid 27044625)
32. Endeman H, Schelfhout V, Voorn GP, et al. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis 2008; 40: 1-6.
33. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454. (Pubitemid 29084777)
34. Steinhauser ML, Hogaboam CM, Kunkel SL, et al. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 1999; 162: 392-399. (Pubitemid 29018946)
35. Terashima T, Amakawa K, Matsumaru A, et al. BAL induces an increase in peripheral blood neutrophils and cytokine levels in healthy volunteers and patients with pneumonia. Chest 2001; 119: 1724-1729. (Pubitemid 32744928)
36. Bruunsgaard H, Skinhoj P, Qvist J, et al. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis 1999; 180: 551-554. (Pubitemid 30256347)
37. van der Poll T, Keogh CV, Guirao X, et al. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 1997; 176: 439-444. (Pubitemid 27328767)
38. Arva E, Andersson B. Induction of phagocyte-stimulating and Th1-promoting cytokines by in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae. Scand J Immunol 1999; 49: 417-423. (Pubitemid 29185427)
39. Arva E, Andersson B. Kinetics of cytokine release and expression of lymphocyte cell-surface activation markers after in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae. Scand J Immunol 1999; 49: 237-243. (Pubitemid 29119433)
40. Lauw FN, Branger J, Florquin S, et al. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J Immunol 2002; 168: 372-378. (Pubitemid 34014139)
41. Rubins JB, Pomeroy C. Role of c interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun 1997; 65: 2975-2977. (Pubitemid 27264133)
42. Schaaf B, Rupp J, Muller-Steinhardt M, et al. The interleukin-6 -174 promoter polymorphism is associated with extrapulmonary bacterial dissemination in Streptococcus pneumoniae infection. Cytokine 2005; 31: 324-328. (Pubitemid 41097369)
43. Temple SE, Lim E, Cheong KY, et al. Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 2003; 55: 629-632. (Pubitemid 38085116)
44. Fijen JW, Tulleken JE, Hepkema BG, et al. The influence of tumor necrosis factor-α and interleukin-10 gene promoter polymorphism on the inflammatory response in experimental human endotoxemia. Clin Infect Dis 2001; 33: 1601-1603. (Pubitemid 34246159)
45. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376. (Pubitemid 28467565)
46. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, et al. Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 2003; 20: 218-223.
47. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167: 512-520.
48. Monton C, Ewig S, Torres A, et al. Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J 1999; 14: 218-220. (Pubitemid 29411261)
49. Vernooy JH, Kucukaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002; 166: 1218-1224. (Pubitemid 35222599)
50. Pinto-Plata VM, Livnat G, Girish M, et al. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007; 131: 37-43. (Pubitemid 46122972)
51. Mufson MA. Pneumococcal pneumonia. Curr Infect Dis Rep 1999; 1: 57-64.
52. Friedman H, Yamamoto Y, Newton C, et al. Immunologic response and pathophysiology of Legionella infection. Semin Respir Infect 1998; 13: 100-108. (Pubitemid 28268625)
53. Tanaka H, Narita M, Teramoto S, et al. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest 2002; 121: 1493-1497. (Pubitemid 34499661)